Share-based Payment Arrangement, Expense in USD of Xenetic Biosciences, Inc. from Q1 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xenetic Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2015 to Q3 2025.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $16K, a 42.9% decline year-over-year.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $104K, a 29.3% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $200K, a 33.3% decline from 2023.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $300K, a 40% decline from 2022.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $500K, a 25% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Xenetic Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $104K $16K -$12K -42.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $116K $16K -$26K -61.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $142K $19K -$58K -75.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $200K $53K +$53K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-18
Q3 2024 $147K $28K -$72K -72% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $219K $42K -$58K -58% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $277K $77K -$23K -23% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $300K $0 -$200K -100% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-18
Q3 2023 $500K $100K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $500K $100K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $500K $100K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $500K $200K +$100K +100% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $400K $100K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $400K $100K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $400K $100K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $400K $100K -$11.9K -10.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $412K $100K -$10.8K -9.75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $423K $100K -$11.7K -10.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $434K $100K -$65.6K -39.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $500K $112K -$11.1K -9.04% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $511K $111K -$137K -55.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $648K $112K -$137K -55.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $785K $166K -$68.3K -29.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $854K $123K -$134K -52.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $987K $247K -$76K -23.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.06M $249K -$196K -44.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.26M $234K -$172K -42.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $1.43M $257K -$44.7K -14.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $1.48M $323K +$21.5K +7.12% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $1.46M $446K -$78.3K -14.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.53M $406K -$260K -39% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $1.79M $301K -$288K -48.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $2.08M $302K -$315K -51.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.4M $524K -$1.21M -69.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $3.6M $666K +$380K +132% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $3.22M $589K +$290K +96.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $2.93M $617K -$1.44M -70% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $4.38M $1.73M +$1.64M +1825% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $2.73M $286K +$139K +94.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $2.59M $299K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $2.06M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $90K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $147K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16

Xenetic Biosciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $200K -$100K -33.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $300K -$200K -40% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $500K +$100K +25% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $400K -$100K -20% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $500K -$354K -41.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $854K -$578K -40.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $1.43M -$361K -20.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $1.79M -$1.43M -44.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $3.22M +$631K +24.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $2.59M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.